The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, December 06, 2022
For over 25 years BRANDTECH Scientific, Inc. has represented the BRAND Group as the US and Canadian supplier of dependable, high-quality laboratory ...
read more
Tuesday, December 06, 2022
Roche announced the appointment of Brad Moore as president and CEO of Roche Diagnostics North America, effective January 1, 2023.
read more
Friday, December 02, 2022
Eli Lilly and Company announced the successful completion of its acquisition of Akouos, Inc. The acquisition expands Lilly's efforts in genetic ...
read more
Thursday, December 01, 2022
Novavax, Inc. announced that the World Health Organization (WHO) has issued an updated Emergency Use Listing (EUL) for Nuvaxovid™ (NVX-CoV2373) COVID-...
read more
Thursday, December 01, 2022
Roivant Sciences and Pfizer Inc. announced formation of a new Vant to develop and commercialize PF-06480605 (now RVT-3101). RVT-3101 is a fully human ...
read more
Thursday, December 01, 2022
Wheeler Bio, Inc., a contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of mammalian-...
read more
Tuesday, November 29, 2022
Bristol Myers Squibb Canada (BMS) announced that Health Canada has approved SOTYKTU (deucravacitinib tablets), the first-in-its-class oral tablet for ...
read more
Tuesday, November 29, 2022
Immutep Limited has signed a Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer for a new Phase I ...
read more
Wednesday, November 23, 2022
Triastek, Inc. has received clearance for its Investigational New Drug (IND) application from the United States Food and Drug Administration (FDA) to ...
read more
Wednesday, November 23, 2022
Takeda announced that the FDA accepted and granted priority review of the Biologics License Application (BLA) for TAK-003, the company’s ...
read more
Wednesday, November 23, 2022
Ascletis Pharma Inc. announced that the FDA approved the Investigational New Drug (IND) application of ASC11, an oral inhibitor drug candidate ...
read more
Wednesday, November 23, 2022
The U.S. Food and Drug Administration approved Hemgenix (etranacogene dezaparvovec), an adeno-associated virus vector-based gene therapy for the ...
read more
Monday, November 21, 2022
Jazz Pharmaceuticals plc announced the FDA approval of a supplemental Biologics License Application (sBLA) to add a Monday/Wednesday/Friday (MWF) ...
read more
Monday, November 21, 2022
Takeda Canada announced that TAKHZYRO (lanadelumab), the first approved monoclonal antibody for the treatment of Hereditary Angioedema (HAE) has been ...
read more
Monday, November 21, 2022
Genmab A/S announced that the FDA accepted for Priority Review the Biologics License Application (BLA) for subcutaneous epcoritamab (DuoBody®-CD3xCD20...
read more